Abstract
Background and ObjectivesPredictive factors for rituximab (RTX) response in rheumatoid arthritis (RA) patients are currently still under debate. Repeated re-treatment is now the rule, but it is worth knowing if...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have